NO922229L -
PEPTID DERIVATIVE, PROCEDURE FOR THE PREPARATION OF THESE PHARMACEUTICAL PREPARATIONS CONTAINING THESE AND PROCEDURES FOR TREATING GLAUCOMA
- Google Patents
PEPTID DERIVATIVE, PROCEDURE FOR THE PREPARATION OF THESE PHARMACEUTICAL PREPARATIONS CONTAINING THESE AND PROCEDURES FOR TREATING GLAUCOMA
Info
Publication number
NO922229L
NO922229LNO92922229ANO922229ANO922229LNO 922229 LNO922229 LNO 922229LNO 92922229 ANO92922229 ANO 92922229ANO 922229 ANO922229 ANO 922229ANO 922229 LNO922229 LNO 922229L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK615889Aexternal-prioritypatent/DK167813B1/en
Application filed by Carlbiotech Ltd AsfiledCriticalCarlbiotech Ltd As
Publication of NO922229D0publicationCriticalpatent/NO922229D0/en
Publication of NO922229LpublicationCriticalpatent/NO922229L/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Peptidderivativer med 3 til 5 eventuelt substituerte aminosyrer, fremgangsmåte for fremstilling av pep- tldene, en farmasøytisk sammensetning Inneholdende minst et peptldderlvatlv som er aktivt mot glaucoma og intraokkulær hypertensjon og en fremgangsmåte for behandling av glaucoma og interokkulær hypertensjon.Peptide derivatives having 3 to 5 optionally substituted amino acids, a process for the preparation of the peptides, a pharmaceutical composition containing at least one peptide derivative active against glaucoma and intraocular hypertension and a method of treating glaucoma and interocular hypertension.
NO92922229A1989-12-071992-06-05
PEPTID DERIVATIVE, PROCEDURE FOR THE PREPARATION OF THESE PHARMACEUTICAL PREPARATIONS CONTAINING THESE AND PROCEDURES FOR TREATING GLAUCOMA
NO922229L
(en)
Compound process peptide fragment to treat a disease in a patient in need of antioangiogenesis therapy single or double-stranded polynucleotide vector composition and process for producing a soluble kringle 5 peptide fragment or 5 kringle fusion protein